IB Acquisition Corp. (IBAC) is a blank-check SPAC with no operating assets, no inventory, no PP&E, and no intangibles. Under the liquidation lens, recovery to equity is driven entirely by the relationship between trust account assets and total claims against the entity. As of March 31, 2026, the trust account holds approximately $8.19M (Level 1, money market fund invested in U.S. Treasuries). Outside the trust, unrestricted cash is $4,634 — effectively zero for operational purposes. The MFFAIS CLV/LLV/OLV is reported at negative $997K, consistent with the working capital deficit of $1.55M disclosed in the going concern note. Permanent equity is in deficit; the $8.33M of common stock subject to possible redemption (temporary equity) represents the contractual claim of remaining public shareholders, which at redemption value approximates the trust balance. In a liquidation scenario, the trust distributes pro rata to public shareholders, but only after satisfying any creditor claims and tax obligations that survive wind-up. Key liability exposures in a wind-down: (1) excise tax payable of $1.14M due April 30, 2026 — a hard cash obligation already accrued, arising from the 1% IR Act excise tax on $106.1M in September 2025 redemptions and $7.9M in March 2026 redemptions; (2) accrued CFO administrative fees; (3) due-to-sponsor balance of $10,788 (non-interest bearing, due on demand). No deferred underwriting fee survives a failed combination under the disclosed terms. The M&A fee of $4.03M to I-Bankers is contingent on closing and would not be payable on liquidation. The $4.03M contingent fee therefore does not reduce the liquidation pool. Trust erosion has been dramatic: the original $115.6M trust has been reduced to $8.19M through two extension redemptions totaling approximately $114M in aggregate outflows. The Second Extension Amendment (approved March 25, 2026, six days before period end) gave the company until September 28, 2026 to close a Business Combination Agreement signed March 16, 2026 with GNQ Insilico Inc. (a Canadian AI/biotech). The BCA requires minimum net tangible assets of $5.0M at closing and a Form S-4 registration. With $8.19M in trust against $1.14M excise tax payable plus operating burn, the margin above the $5.0M NTA floor is thin. Management has concluded substantial doubt about going concern exists. TAG_CONTEXT provided zero XBRL tags for this filing period, so all balance-sheet values referenced above are derived from narrative disclosures in the filing body.
▼ Community Notes